Insmed Incorporated (NASDAQ:INSM – Get Free Report)’s stock price traded up 3.2% on Thursday . The company traded as high as $26.34 and last traded at $26.33. 403,165 shares traded hands during trading, a decline of 67% from the average session volume of 1,224,588 shares. The stock had previously closed at $25.52. Analyst Ratings Changes […]
WCM Investment Management LLC grew its stake in Insmed Incorporated (NASDAQ:INSM – Free Report) by 9.7% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 284,621 shares of the biopharmaceutical company’s stock after purchasing an additional 25,097 shares during the period. WCM Investment Management LLC’s holdings in Insmed were worth $5,986,000 as of its […]
Atom Investors LP increased its position in shares of Insmed Incorporated (NASDAQ:INSM – Free Report) by 75.4% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 40,224 shares of the biopharmaceutical company’s stock after buying an additional 17,293 shares during the period. […]
Insmed (NASDAQ:INSM – Free Report) had its price objective boosted by Evercore ISI from $32.00 to $42.00 in a report issued on Thursday morning, Marketbeat reports. Evercore ISI currently has an outperform rating on the biopharmaceutical company’s stock. A number of other research firms also recently weighed in on INSM. HC Wainwright restated a buy […]
Long Focus Capital Management LLC lowered its holdings in Insmed Incorporated (NASDAQ:INSM – Free Report) by 33.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 215,057 shares of the biopharmaceutical company’s stock after selling 109,943 shares during the period. Long Focus […]